Background:
Population screening reduces mortality from colorectal cancer, yet factors associated with uptake of screening are incompletely understood.
Purpose:
The purpose of the study was to determine demographic and psychosocial factors associated with participation in faecal occult blood test (FOBT)-based colorectal cancer (CRC) screening in an average risk community programme in Adelaide, South Australia.
Method:
A questionnaire consistent with the Preventive Health Model was used to determine demographic and psychosocial differences between previous FOBT-based screening participants (n = 413, response rate 93.2%) and non-participants (n = 481, response rate 47.9%). Results were analysed by univariate and multivariate generalised linear modelling, and factors associated with participation were identified.
Results:
Factor analysis of psychosocial items revealed an optimal three-factor solution (knowledge, faecal aversion, belief in the value of screening). Following multivariate analyses, two psychosocial and two demographic factors remained as predictors of FOBT screening behaviour: (1) items related to faecal aversion (Aversion), relative risk (RR) = 0.61, CI = 0.55-0.69, (2) perceptions about the value of screening (Value), RR = 1.45, CI = 1.13-1.85, (3) age band 65-69 (Age, five age bands, relative to age 50-54), RR = 1.43, CI = 1.16-1.76 and FOBT type (Test; three tests, Hemoccult, FlexSure, InSure randomly assigned, relative to Hemoccult: FlexSure: RR = 1.41, CI = 1.17-1.71, InSure: RR = 1.76, CI = 1.47-2.11.
Conclusions:
The psychosocial factors associated with non-participation in FOBT-based CRC screening are amenable to interventions designed to improve participation. The small relative risks values associated with each predictor, however, raise the possibility that additional factors are likely to influence screening participation.
Citing Articles
Faecal immunochemical test for suspected colorectal cancer symptoms: patient survey of usability and acceptability.
Georgiou Delisle T, DSouza N, Davies B, Benton S, Chen M, Ward H
BJGP Open. 2021; 6(1).
PMID: 34645655
PMC: 8958743.
DOI: 10.3399/BJGPO.2021.0102.
The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens.
Osborne J, Flight I, Wilson C, Chen G, Ratcliffe J, Young G
Patient Prefer Adherence. 2018; 12:1825-1836.
PMID: 30271126
PMC: 6154741.
DOI: 10.2147/PPA.S172143.
Predictors of colorectal cancer screening intention among Iranian adults: an application of the preventive health model.
Besharati F, Karimi-Shahanjarini A, Hazavehie S, Bashirian S, Faradmal J
J Prev Med Hyg. 2018; 59(2):E159-E166.
PMID: 30083624
PMC: 6069407.
Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
Hategekimana C, Karamouzian M
Int J Health Policy Manag. 2016; 5(6):365-71.
PMID: 27285514
PMC: 4885727.
DOI: 10.15171/ijhpm.2016.14.
A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.
Symonds E, Pedersen S, Baker R, Murray D, Gaur S, Cole S
Clin Transl Gastroenterol. 2016; 7:e137.
PMID: 26765125
PMC: 4737873.
DOI: 10.1038/ctg.2015.67.
Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study.
Gordon N, Green B
BMC Public Health. 2015; 15:546.
PMID: 26062732
PMC: 4462185.
DOI: 10.1186/s12889-015-1908-x.
A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
Wilson C, Flight I, Turnbull D, Gregory T, Cole S, Young G
BMC Med Inform Decis Mak. 2015; 15:25.
PMID: 25886492
PMC: 4403749.
DOI: 10.1186/s12911-015-0147-5.
Patient Beliefs About Colon Cancer Screening.
Ely J, Levy B, Daly J, Xu Y
J Cancer Educ. 2015; 31(1):39-46.
PMID: 25619196
PMC: 7712459.
DOI: 10.1007/s13187-015-0792-5.
Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.
Duncan A, Turnbull D, Wilson C, Osborne J, Cole S, Flight I
BMC Public Health. 2014; 14:238.
PMID: 24606951
PMC: 4234274.
DOI: 10.1186/1471-2458-14-238.
Self-reported bowel screening rates in older Australians and the implications for public health screening programs.
Zajac I, Flight I, Turnbull D, Young G, Cole S, Wilson C
Australas Med J. 2013; 6(8):411-7.
PMID: 24039635
PMC: 3767029.
DOI: 10.4066/AMJ.2013.1808.
Decision Support and the Effectiveness of Web-based Delivery and Information Tailoring for Bowel Cancer Screening: An Exploratory Study.
Flight I, Wilson C, Zajac I, Hart E, McGillivray J
JMIR Res Protoc. 2013; 1(2):e12.
PMID: 23611950
PMC: 3626147.
DOI: 10.2196/resprot.2135.
Editorial for International Journal of Behavioral Medicine: special issue on cancer.
Antoni M
Int J Behav Med. 2011; 18(4):288-92.
PMID: 21989532
DOI: 10.1007/s12529-011-9200-7.
Responses to procedural information about colorectal cancer screening using faecal occult blood testing: the role of consideration of future consequences.
Von Wagner C, Good A, Smith S, Wardle J
Health Expect. 2011; 15(2):176-86.
PMID: 21501350
PMC: 5060610.
DOI: 10.1111/j.1369-7625.2011.00675.x.
Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer.
Gregory T, Wilson C, Duncan A, Turnbull D, Cole S, Young G
BMC Public Health. 2011; 11:38.
PMID: 21232156
PMC: 3034679.
DOI: 10.1186/1471-2458-11-38.